And thirdly, in the aftermath of the COVID-19 pandemic, which caused significant delays across all aspects of clinical studies undertaken globally, many clinical studies in Australia are now in the same post-clinical stage and this is creating backlogs and delays with the CROs involved in the studies
BIT Price at posting:
10.5¢ Sentiment: Buy Disclosure: Held
